| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9309121 | Kidney International | 2005 | 8 Pages |
Abstract
Lower hematocrit is an important risk factor for contrast-induced nephropathy. Whether correcting the hematocrit prepercutaneous coronary intervention might decrease the rates of contrast-induced nephropathy should be addressed in a prospectively designed trial.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Eugenia Nikolsky, Roxana Mehran, Zoran Lasic, Gary S. Mintz, Alexandra J. Lansky, Yingbo Na, Stuart Pocock, Manuela Negoita, Issam Moussa, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, George Dangas,